AKTS
#2218
Aktis Oncology, Inc. - Common stock
25.7 8 USD
-0.02%
Market Price
Sector: Technology
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-1.53%
Monthly Change
+15.92%
6 month change
+28.32%
Year Change
-4.52%
Previous Close
26.1 8
Open
25.7 8
Low
25.7 8
High
25.7 8
Volume
36
Financials
- Market Capitalization 1.43 B
- Employee 79
- Founded 2020
- CEO N/A
- Website www.aktisoncology.com
- Headquarter Delaware, United States
- FIGI BBG00ZQS8KZ1
- Industry Communication Equipment
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1738 |  EXTR Extreme Networks, Inc. - Common Stock | 22.58 USD | -2.80% | +0.71% | -24.86% | +9.40% | 2.95 B USD | ||
| 1756 |  DGII Digi International Inc. - Common Stock | 75.77 USD | -2.17% | +1.75% | +12.99% | +122.72% | 2.88 B USD | ||
| 2234 |  VISN Vistance Networks, Inc. - Common Stock | 6.06 USD | -47.89% | -45.45% | -48.60% | -68.44% | 1.40 B USD | ||
| 2286 |  HLIT Harmonic Inc. - Common Stock | 12.02 USD | -2.12% | -1.96% | +8.98% | +14.69% | 1.31 B USD |
Frequently asked questions about Aktis Oncology, Inc. Common stock
What is the Aktis Oncology, Inc. Common stock stock price today?
The current price of Aktis Oncology, Inc. Common stock (AKTS) is 25.78. Over the past 24 hours, the stock has changed by -1.53%. Follow the AKTS chart for real-time price dynamics.
What is the stock ticker of Aktis Oncology, Inc. Common stock?
Aktis Oncology, Inc. Common stock trades under the ticker AKTS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Aktis Oncology, Inc. Common stock stock going up?
AKTS has changed by +6.75% over the last week, +15.92% over the last month, and -4.52% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Aktis Oncology, Inc. Common stock?
Aktis Oncology, Inc. Common stock currently has a market capitalization of 1.43 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Aktis Oncology, Inc. Common stock earnings last quarter?
Last quarter, Aktis Oncology, Inc. Common stock reported earnings of -0.44 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Aktis Oncology, Inc. Common stock revenue for the last quarter?
Aktis Oncology, Inc. Common stock reported quarterly revenue of 3.38 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Aktis Oncology, Inc. Common stock net income for the last quarter?
Aktis Oncology, Inc. Common stock reported net income of -24.14 M for the last quarter. The previous quarter showed -18.32 M, which means net income changed by -31.75%.
How many employees does Aktis Oncology, Inc. Common stock have?
As of the latest available data, Aktis Oncology, Inc. Common stock has 79 employees. Workforce size can provide additional context about the company's scale and operations.
What is Aktis Oncology, Inc. Common stock EBITDA?
Aktis Oncology, Inc. Common stock EBITDA is -28.02 M, and its EBITDA margin is -828.01%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Aktis Oncology, Inc. Common stock stock?
You can buy Aktis Oncology, Inc. Common stock (AKTS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Aktis Oncology, Inc. Common stock stock?
Investing in Aktis Oncology, Inc. Common stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the AKTS chart and related analysis on metatrader.com as part of your research.